MetLife Series A Preferred Stock
MET.PRA
3 hedge funds and large institutions have $3.69M invested in MetLife Series A Preferred Stock in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 2 reducing their positions, and 2 closing their positions.
0.01% less ownership
Funds ownership: 0.65% → 0.63% (-0.01%)
40% less funds holding
Funds holding: 5 → 3 (-2)
100% less capital inflows, than outflows
Capital inflows: $0 | Capital outflows: $72.1K
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OP
ORG Partners
Roanoke,
Indiana
|
-$29.4K |
| 2 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$29.3K |
| 3 |
Tower Bridge Advisors
Conshohocken,
Pennsylvania
|
-$8.57K |
| 4 |
Thurston Springer Miller Herd & Titak
Indianapolis,
Indiana
|
-$4.9K |
MET.PRA Hedge Fund Activity: Q3 2024 in Review
3 of the 6,991 institutional investors tracked by Wall St. Rank reported a position in MetLife Series A Preferred Stock (MET.PRA) for Q3 2024, worth a combined $3.69M — down 2.7% from $3.8M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of MET.PRA and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 0 added.
The largest seller was ORG Partners, exiting entirely with an estimated $29.4K sold.
- 3 institutional investors held MetLife Series A Preferred Stock (MET.PRA) as of Q3 2024, down from 5 in Q2 2024.
- Funds reported $3.69M of MetLife Series A Preferred Stock stock for Q3 2024, down 2.7% quarter-over-quarter.
- 0 funds opened new MetLife Series A Preferred Stock positions in Q3 2024 and 2 closed out, a net change of -2 holders.
- The largest MetLife Series A Preferred Stock seller in Q3 2024 was ORG Partners, an estimated $29.4K sold.
Based on aggregated 13F filings for Q3 2024.